Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer.

P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer. Med Oncol. 2013; 30(2):567.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.